Suppr超能文献

胶原酶注射治疗掌腱膜挛缩症后行有限掌腱膜切除术的围手术期并发症

Perioperative Complications Associated With Limited Surgical Fasciectomy After Collagenase Clostridium Histolyticum for Dupuytren Contracture.

机构信息

Brigham and Women's Hospital, Boston, MA, USA.

Harvard Medical School, Boston, MA, USA.

出版信息

Hand (N Y). 2024 Sep;19(6):946-950. doi: 10.1177/15589447231160288. Epub 2023 Apr 4.

Abstract

BACKGROUND

The purpose of this study was to determine the perioperative complication rate of surgical fasciectomy following previous treatment with collagenase clostridium histolyticum (CCH) treatment in patients with Dupuytren disease.

METHODS

A retrospective review of all patients at a large health system undergoing CCH treatment and subsequent limited surgical fasciectomy for recurrence on the same digit between 2010 and 2020 was performed. Fifty-two patients with 62 affected digits met inclusion criteria, and cases were reviewed for preoperative demographics, treatment characteristics, clinical outcomes, and perioperative complications.

RESULTS

Fifty-five digits in 48 patients were treated with CCH and underwent subsequent limited surgical fasciectomy. Of all digits in the present study, 3 (6.3%) had a documented surgical complication following open surgical fasciectomy. There were zero postoperative infections, vascular injuries, or tendon injuries. The rate of nerve injury was 2.1%. The rate of postoperative skin necrosis was 4.2%. These rates were comparable or lower than those of historical published data.

CONCLUSIONS

The rate of perioperative complications in patients undergoing limited surgical fasciectomy after previous CCH treatment is low. The findings of this study will aid the counseling of Dupuytren patients in deciding whether to pursue treatment with CCH versus open surgical fasciectomy.

摘要

背景

本研究旨在确定先前接受胶原酶梭菌(CCH)治疗的患者在患有杜普伊特伦病后接受手术筋膜切开术的围手术期并发症发生率。

方法

对 2010 年至 2020 年期间在大型医疗系统中接受 CCH 治疗且同一手指上出现复发的患者进行回顾性研究,对接受 CCH 治疗且随后在同一手指上进行有限手术筋膜切开术的所有患者进行回顾性研究。52 例患者的 62 个受累手指符合纳入标准,对患者的术前人口统计学、治疗特征、临床结果和围手术期并发症进行了病例回顾。

结果

55 个手指在 48 例患者中接受 CCH 治疗,并随后接受了有限的手术筋膜切开术。在本研究的所有手指中,有 3 个(6.3%)在开放性手术筋膜切开术后有记录的手术并发症。术后无感染、血管损伤或肌腱损伤。神经损伤的发生率为 2.1%。术后皮肤坏死的发生率为 4.2%。这些比率与历史发表的数据相当或更低。

结论

在先前接受 CCH 治疗的患者中,接受有限手术筋膜切开术的围手术期并发症发生率较低。本研究的结果将有助于对杜普伊特伦病患者进行咨询,以决定是否采用 CCH 治疗还是开放性手术筋膜切开术。

相似文献

3
Surgery for Dupuytren's contracture of the fingers.
Cochrane Database Syst Rev. 2015 Dec 9;2015(12):CD010143. doi: 10.1002/14651858.CD010143.pub2.
4
Surgical Management of Dupuytren Disease: A Systematic Review and Network Meta-analyses.
Hand (N Y). 2024 Nov;19(8):1283-1292. doi: 10.1177/15589447231174175. Epub 2023 May 28.
7
Collagenase clostridium histolyticum in Dupuytren's contracture: a systematic review.
Br Med Bull. 2016 Jun;118(1):149-58. doi: 10.1093/bmb/ldw020. Epub 2016 May 5.
8
Effectiveness and Safety of Dupuytren Contracture Treatments: A Systematic Review and Meta-Analysis Using the GRADE Approach.
Plast Reconstr Surg. 2025 Sep 1;156(3):375e-384e. doi: 10.1097/PRS.0000000000011816. Epub 2024 Oct 15.

本文引用的文献

1
Current Concepts in the Management of Dupuytren Disease of the Hand.
J Am Acad Orthop Surg. 2021 Jun 1;29(11):462-469. doi: 10.5435/JAAOS-D-20-00190.
2
Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: 2-Year Follow-up.
Clin Orthop Surg. 2019 Sep;11(3):332-336. doi: 10.4055/cios.2019.11.3.332. Epub 2019 Aug 12.
3
Fasciectomy for Dupuytren Contracture.
Hand Clin. 2018 Aug;34(3):351-366. doi: 10.1016/j.hcl.2018.04.002.
4
Treatment of Dupuytren Contracture With Injectable Collagenase Within the Veterans Affairs System.
JAMA Surg. 2017 Feb 1;152(2):204-205. doi: 10.1001/jamasurg.2016.3605.
5
The Impact of Collagenase Clostridium histolyticum Introduction on Dupuytren Treatment Patterns in the United States.
J Hand Surg Am. 2016 Oct;41(10):963-968. doi: 10.1016/j.jhsa.2016.07.090. Epub 2016 Aug 18.
6
Salvage palmar fasciectomy after initial treatment with collagenase clostridium histolyticum.
Plast Reconstr Surg. 2015 Jun;135(6):1000e-1006e. doi: 10.1097/PRS.0000000000001282.
7
A systematic review and meta-analysis on the prevalence of Dupuytren disease in the general population of Western countries.
Plast Reconstr Surg. 2014 Mar;133(3):593-603. doi: 10.1097/01.prs.0000438455.37604.0f.
8
Prevalence of Dupuytren disease in The Netherlands.
Plast Reconstr Surg. 2013 Aug;132(2):394-403. doi: 10.1097/PRS.0b013e3182958a33.
9
Surgical findings in the treatment of Dupuytren's disease after initial treatment with clostridial collagenase (Xiaflex).
J Hand Surg Eur Vol. 2014 Jun;39(5):463-5. doi: 10.1177/1753193413488305. Epub 2013 May 6.
10
Prevalence, incidence, and treatments of Dupuytren's disease in the United States: results from a population-based study.
Hand (N Y). 2011 Jun;6(2):149-58. doi: 10.1007/s11552-010-9306-4. Epub 2010 Nov 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验